Buy Affimed Stock | AFMD Stock Price & Latest News | Public
AFMD

Affimed

$0.00 (0.00%)Today

    About AFMD

    Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany. The full company name is Affimed NV....

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.13
    -0.19
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    Actual EPS
    Q4 2020

    Stats

    Market Cap$403,36M
    Volume20,04k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.46
    1 Year Low$1.42
    Open$5.24
    High$5.45
    Low$5.22

    Buy any stock with any amount of money.

    Download the App
    Download the app